Tristel plc (AIM:TSTL)
London · Delayed Price · Currency is GBP · Price in GBX 366.00
-4.00 (-1.08%)
Sep 9, 2025, 3:16 PM GMT+1
Tristel Market Cap
Tristel has a market cap or net worth of 176.57 million as of September 9, 2025. Its market cap has decreased by -21.93% in one year.
Market Cap
176.57M
Enterprise Value
170.79M
Revenue
43.56M
Ranking
n/a
PE Ratio
28.72
Stock Price
366.00
Market Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 176.57M, an increase of 2,456.38%. That is a compound annual growth rate of 17.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 176.57M | -12.89% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | 245.16M | 42.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |